Recent Updates
Recently added Catalysts
EUDA Positive Sentiment Score: 65/100

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement SINGAPORE

Key Takeaway: EUDA Health Holdings Limited has announced a second amendment to its warrant agreement with Streeterville Capital, reducing the exercise price from $4.00 to $2.00 per share. This adjustment also lowers the minimum closing price requirement for forced exercise from $6.00 to $3.00. CEO Alfred Lim stated that this change is aimed at aligning the warrant terms with current market conditions while maintaining focus on the company's long-term strategy. The company continues to prioritize preventive and longevity-focused healthcare solutions in Asia.

Market Sentiment Analysis

POSITIVE FACTORS

  • Reduction in exercise price of the warrant to stimulate investment
  • Alignment of warrant terms with current market conditions
  • Continued commitment to long-term strategy in healthcare
  • Focus on proactive and preventive healthcare solutions

Full Press Release Details

Health Announces Second Amendment to Streeterville Warrant Agreement
Jan. 15, 2026 (GLOBE NEWSWIRE) - EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"),
a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has entered
into a second amendment to its previously disclosed warrant agreement with Streeterville Capital, LLC.
of Second Warrant Amendment Terms
the terms of the Second Warrant Amendment dated January 13, 2026, the Company and Streeterville Capital agreed to further reduce the
exercise price of the warrant from US$4.00 per share to US$2.00 per share. In addition, the minimum closing price of the Company's
ordinary shares required to trigger a forced exercise under the warrant was reduced from US$6.00 to US$3.00. All other terms of the warrant
Alfred Lim, Chief Executive Officer of EUDA, commented:
view this second amendment as a technical adjustment to align the warrant terms with current market conditions and to preserve flexibility
in our capital structure. It does not change our long-term strategy or operational priorities, and we remain focused on executing our
business plan across preventive health, longevity solutions, and personalised healthcare."
EUDA Health Holdings Limited
Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore,
Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the
fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which
is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and
science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment
to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.
document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words,
such as the words "estimates," "projected," "expects," "envisions," "anticipates,"
"forecasts," "plans," "intends," "believes," "seeks," "may,"
"will," "should," "future," "propose" and variations of these words or similar expressions
(or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions
or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are
outside EUDA's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking
statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document.
The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.

Frequently Asked Questions

What did EUDA Health announce on January 15, 2026?

EUDA Health announced a second amendment to its warrant agreement with Streeterville Capital.

What changes were made in the Second Warrant Amendment?

The exercise price was reduced from $4.00 to $2.00, and forced exercise conditions changed.

Who is the CEO of EUDA Health Holdings Limited?

Alfred Lim serves as the Chief Executive Officer of EUDA Health Holdings Limited.

What is EUDA's focus in the healthcare sector?

EUDA focuses on non-invasive and preventive healthcare, targeting longevity solutions.

How does EUDA plan to address healthcare needs in Asia?

EUDA aims to meet evolving healthcare needs by providing innovative, accessible health solutions.

Last updated: Jan 15, 2026